| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VYNE Therapeutics Inc. | Director | Stock Option (right to buy) | 20,000 | 12 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VYNE | VYNE Therapeutics Inc. | 12 Dec 2024 | 1 | $0 | 4 | Director | 13 Dec 2024, 16:15 |
| VYNE | VYNE Therapeutics Inc. | 01 Jan 2024 | 1 | $0 | 4 | Director | 03 Jan 2024, 17:11 |
| VYNE | VYNE Therapeutics Inc. | 13 Dec 2023 | 1 | $0 | 4 | Director | 15 Dec 2023, 17:04 |
| VYNE | VYNE Therapeutics Inc. | 10 Aug 2022 | 1 | $0 | 4 | Director | 12 Aug 2022, 17:11 |
| VYNE | VYNE Therapeutics Inc. | 19 Jul 2021 | 1 | $0 | 4 | Director | 20 Jul 2021, 17:05 |